 It has been tried in treatment-resistant cases of schizophrenia with some (albeit limited) success.It has also been reported effective in the treatment of L-DOPA and other forms of psychosis in Parkinson's disease (although a multicentre, double-blind, placebo-controlled study conducted in 2012 failed to support these findings).It is also known to possess anxiolytic properties.